v3.26.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING AND NON-RECURRING BASIS

The following table provides a summary of financial assets and liabilities measured at fair value on a recurring and non-recurring basis (in thousands):

 

Description  Fair Value at
December 31,
2025
   Level 1   Level 2   Level 3 
                 
Recurring Assets                    
Cash equivalents                    
Money market funds  $73,854   $73,854   $   $ 
Money market deposit account   182    182         
Short-term investments                    
U.S. treasury securities   25,088    25,088         
U.S. federal agency securities   17,774        17,774     
Certificates of deposit   70,105        70,105     
Total assets measured at fair value  $187,003   $99,124   $87,879   $ 
                     
Liabilities                    
Warrant liabilities  $18,902   $   $   $18,902 
Total liabilities measured at fair value  $18,902   $   $   $18,902 

 

Description   Fair Value at
December 31,
2024
    Level 1     Level 2     Level 3  
                         
Recurring Assets                                
Cash equivalents                                
Money market funds   $ 17,627     $ 17,627     $     $  
Money market deposit account     5,109       5,109              
Short-term investments                                
U.S. treasury securities     23,968       23,968              
U.S. federal agency securities     40,375             40,375        
Certificates of deposit     10,020             10,020        
Total assets measured at fair value   $ 97,099     $ 46,704     $ 50,395     $  
                                 
Liabilities                                
Warrant liabilities   $ 32,014     $     $     $ 32,014  
Total liabilities measured at fair value   $ 32,014     $     $     $ 32,014  
SCHEDULE OF OUTSTANDING WARRANT LIABILITIES

As of December 31, 2025 and 2024, the Company had the following outstanding warrants that are classified as warrant liabilities:

 

   2025   2024 
   As of December 31, 
   2025   2024 
         
Warrants issued as part of the 2021 public offering, expiration date December 2026, exercise price of $9.75 per share   1,788,000    1,788,000 
Warrants issued as part of the 2022 Private Placement Offering, expiration date November 2027, exercise price $4.75 per share   5,762,503    7,609,879 
Warrants issued as part of the 2024 Loan Agreement, expiration date January 2029, exercise price $4.07 per share   589,681    589,681 
Warrants issued as part of the 2024 Loan Agreement Amendment, expiration date July 2030, exercise price $6.07 per share   16,474     
SCHEDULE OF ACTIVITY OF WARRANT LIABILITIES

The following table provides a summary of the activity on the warrant liabilities (in thousands):

 

   2025   2024 
   As of December 31, 
   2025   2024 
         
Beginning warrant liabilities  $32,014   $31,352 
Issuance of warrants   80    220 
Reclassification of warrants to equity as part of warrant exercise   (7,053)    
(Gain) loss recognized in earnings from change in fair value   (6,139)   442 
Ending warrant liabilities  $18,902   $32,014 
SCHEDULE OF ESTIMATE FAIR VALUE OF WARRANTS

The following table outlines the key inputs for the Black-Scholes option-pricing model:

 

   As of December 31, 
   2025   2024 
         
Common share price  $5.27   $5.57 
Expected term (years)   0.964.54     1.964.02  
Risk-free interest rate (%)   3.41% – 3.63%    4.16% – 4.24% 
Volatility (%)   78.97% – 100.00%    92.64% – 100.00% 
Expected dividend yield (%)   0%   0%
SCHEDULE OF ACTIVITY OF DERIVATIVE LIABILITIES

The following table provides a summary of the activity on the derivative liabilities (in thousands):

 

   2025   2024 
   As of December 31, 
   2025   2024 
         
Beginning derivative liabilities  $   $ 
Fair value of derivatives issued in connection with Loan Agreement       822 
Loss recognized in earnings from change in fair value       313 
Reclassification of derivative liability in connection with the Loan Agreement       (1,135)
Ending derivative liabilities  $   $